Ajanta Pharma has informed that the Board of Directors of the Company at its meeting held on April 29, 2016, has transacted and recommended that interim dividend declared at the meeting held on March 09, 2016, be considered as final dividend on the equity shares of the Company for the financial year ended March 31, 2016.
The above information is a part of company’s filings submitted to BSE.